Benzaldehyde Ether Tissue Clearing Medium
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing transparent biological tissue samples for light microscopy are limited by the use of toxic embedding media and require complex mixing steps, and samples treated with ethylcinnamate cannot be stored in a refrigerator due to low melting point and high vapor pressure.
Innovation Solution
A procedure using benzaldehyde ethers as embedding media, which can be used as pure substances to match the refractive index of the tissue, allowing for faster penetration and transparency, and can be used with a gradient mixer or single pass dehydration to reduce effort and reagent usage.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If dibenzyl ether is used as embedding medium, then refractive index matching and transparency are achieved, but toxicity increases
Solution Approach 1:
The patent replaces toxic aromatic compounds (dibenzyl ether, benzyl alcohol, benzyl benzoate) with a biodegradable ester compound that can be used as a disposable, non-toxic embedding medium. The ester compound achieves the same refractive index matching function without the harmful toxic effects of the traditional aromatic solvents.
Solution Approach 2:
The patent changes the chemical parameters of the embedding medium by using an ester compound with specific molecular weight and refractive index properties that match tissue while being non-toxic and biodegradable, replacing the traditional aromatic hydrocarbon-based compounds.
2Object-affected harmful factors
If ethyl cinnamate is used as embedding medium, then low toxicity is achieved, but storage capability deteriorates due to low melting point
Solution Approach 1:
The patent modifies the physical parameters of the embedding medium by selecting an ester compound with a melting point above refrigeration temperatures (4°C), ensuring the medium remains liquid and stable during storage. The compound maintains low toxicity while achieving the necessary thermal stability for refrigerator storage.
3Manufacturing precision
If mixing steps are performed to achieve refractive index matching, then transparency is improved, but process complexity increases
Solution Approach 1:
The patent extracts the refractive index matching property into a single pre-formulated ester compound with the exact desired refractive index (1.45-1.55), eliminating the need for complex mixing procedures. The compound is used directly as a pure substance or simple solution, removing the mixing step entirely.
Solution Approach 2:
The refractive index matching is pre-established in the ester compound formulation itself, so no additional mixing or adjustment steps are required during the tissue embedding process. The compound arrives ready-to-use with the correct optical properties.
4Manufacturing precision
If high-purity solvents are used for dehydration, then transparency is improved, but cost and time increase
Solution Approach 1:
The patent replaces expensive high-purity solvents with cost-effective technical-grade solvents (96-98% ethanol, isopropanol, or acetone) that are sufficient for the dehydration process when combined with the novel ester embedding medium. The ester compound tolerates residual impurities while still achieving complete transparency.
Solution Approach 2:
The patent changes the purity requirements of the dehydration solvents from pharmaceutical-grade to technical-grade (96-98%), reducing both cost and preparation time while maintaining the final transparency quality through the synergistic effect of the ester embedding medium.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method provides transparent tissue samples with reduced toxicity, faster preparation times, and cost savings by eliminating the need for high-purity solvents and repeated incubations, while maintaining or improving transparency even with residual water content.
Implementation Method 1
The final step in the various clearing procedures is adjusting the refractive index to that of the tissue being examined under the microscope
Implementation Method 2
In dehydration procedures, the tissue is treated with various mixtures of a water-miscible organic solvent and water. The treatment is carried out with an increasing proportion of the organic solvent to completely remove the water from the tissue
Implementation Method 3
Clarifying the dehydrated tissue sample by immersing it in a liquid embedding medium
Data Source
Figure 1
Figure 2
Figure 3
AI summary
The invention relates to a method for producing transparent tissue samples of biological or human tissue for light microscopic examination, comprising the steps a) dehydrating the tissue sample with a dehydrating solvent and b) clarifying the dehydrated tissue sample by embedding it in a medium containing a benzaldehyde anisole ether. Compared to the embedding media commonly used to date, benzyl benzoate/benzyl alcohol mixtures and methyl salicylate/benzyl benzoate mixtures, benzaldehyde anisole ethers have the advantage that, like dibenzyl ethers, they can be used as a pure substance: Since the pure substance already achieves the desired refractive index, the refractive index does not need to be adjusted by mixing the embedding medium.Furthermore, the benzaldehyde anisole ethers according to the invention penetrate the dehydrated tissue significantly faster than the previously known embedding media and make the tissue transparent more quickly.